Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China
· Delayed Price · Currency is CNY 19.64
+0.16 (0.82%)
Apr 29, 2026, 3:00 PM CST
SHA:600671 Revenue
In the year 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had annual revenue of 211.75M CNY, down -2.55%. Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had revenue of 52.81M in the quarter ending December 31, 2025, a decrease of -42.98%.
Revenue
211.75M
Revenue Growth
-2.55%
P/S Ratio
11.29
Revenue / Employee
584.96K
Employees
362
Market Cap
2.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 211.75M | -5.54M | -2.55% |
| Dec 31, 2024 | 217.30M | 95.52M | 78.44% |
| Dec 31, 2023 | 121.78M | 12.87M | 11.82% |
| Dec 31, 2022 | 108.91M | -38.16M | -25.95% |
| Dec 31, 2021 | 147.07M | -59.56M | -28.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hubei Guangji Pharmaceutical | 638.58M |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Guangdong Jiaying Pharmaceutical | 410.00M |
| Zhejiang Haisen Pharmaceutical | 532.26M |
| Shandong Keyuan Pharmaceutical | 448.33M |
| Hangzhou Minsheng Healthcare | 827.65M |
| Zhejiang Int'l Group | 33.68B |